Health Canada has approved the first generic version of Ozempic, the brand-name diabetes drug made by Danish pharmaceutical company Novo Nordisk.
The department said in a news release that it authorized a generic semaglutide injection submitted by Dr. Reddy’s Laboratories after reviewing evidence showing the product met Health Canada’s requirements for safety, efficacy, and quality for generic drugs.
According to the department, it is the first generic semaglutide approved in Canada and the first authorized in any G7 country.
Health Canada said it is also reviewing eight other generic semaglutide submissions from different companies and expects to make additional regulatory decisions in the coming weeks and months….